Insight Molecular Diagnostics Inc. Common Stock IMDX Business Segments
| FY'25 | ||
|---|---|---|
| Revenue by Product | ||
| Kitted Products | $24K— | |
| Laboratory Services | $4.03M+117% | |
| Non-Current Assets by Geography | ||
| Asia Pacific | $411K— | |
| Europe | $5.62M— | |
| GB | $1.89M— | |
| US | $21.65M— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Insight Molecular Diagnostics Inc. Common Stock break its business down?
- Insight Molecular Diagnostics Inc. Common Stock (IMDX) reports revenue by product across 2 parts — Kitted Products and Laboratory Services. Each is extracted from the segment footnotes and tracked over time.
- Where does Insight Molecular Diagnostics Inc. Common Stock's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Insight Molecular Diagnostics Inc. Common Stock's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
